UK Corporate Compliance Expert Peter Burrell to Join Willkie as a Partner in London
9.5.2011 20:15:58 CEST | Business Wire | Press release
Firm significantly expands international Compliance and Enforcement Practice
Willkie Farr & Gallagher LLP has announced that UK solicitor Peter Burrell will join the firm as a partner in London. Mr. Burrell, the head of Herbert Smith’s Investigations and Corporate Crimes Practice, is recognized internationally as a leading authority on anti-corruption and white collar criminal matters. His broad experience and expertise in this area will greatly enhance Willkie’s ability to assist clients in complying with the new UK Bribery Act. The Act, which completely overhauls UK anti-corruption law, exposes companies doing business in the UK and abroad to criminal liability and potentially severe penalties if they fail to comply with its stringent provisions.
Mr. Burrell specializes in complex and contentious regulatory matters, including conducting and managing internal investigations, either commenced as a result of an internal discovery or in response to an external investigation by the UK Serious Fraud Office (SFO), HM Revenue & Customs, Department for Business, Innovation and Skills, or the Financial Services Authority. He also advises clients on controls and procedures regarding money laundering and financial crime prevention, and on criminal liability issues, with a particular focus on anti-corruption policies and procedures. Mr. Burrell is regularly sought to manage and conduct criminal investigations and proceedings, as well as acting for clients in associated civil litigation. He has handled some of the most noteworthy SFO prosecutions, including acting for Severn Trent Plc and Mabey & Johnson in the SFO’s first prosecution of a company for overseas corruption and the first use of the Attorney General’s Plea Bargaining Guidelines.
Tom Cerabino, co-chair of Willkie Farr & Gallagher, said “We are delighted to have a solicitor with Peter’s credentials and reputation join us in London. Recruiting Peter is one further step in the development and expansion of our European network, and we look forward to working with Peter to expand our highly regarded practice in the compliance and enforcement area.”
Martin Weinstein, who chairs the firm’s Compliance and Enforcement Practice stated: “The UK Bribery Act is expected to have a significant impact on global anti-corruption compliance by multinational companies. Willkie already has one of the preeminent U.S.-based anti-corruption practices. With the addition of Peter in London, we will have market-leading expertise on both sides of the Atlantic. We look forward to working with Peter to provide the very best team to service our multinational clients’ needs.”
Willkie’s Compliance and Enforcement Practice, recognized globally as among the very best in the field, includes a number of former U.S. Department of Justice prosecutors and two former SEC Assistant Directors. Willkie’s significant FCPA experience, successes and overall knowledge base place it among a select few international firms that will be prepared to assist clients with the increasingly complex risks and challenges associated with international anti-corruption compliance and enforcement. Mr. Burrell is expected to join the firm as soon as he is free to do so under his existing arrangements with Herbert Smith.
Willkie Farr & Gallagher LLP is an international law firm of approximately 630 attorneys with offices in New York, Washington, Paris, London, Milan, Rome, Frankfurt and Brussels. The firm is headquartered in New York City at 787 Seventh Avenue. Tel: 212.728.8000.
Contact:
Willkie Farr & Gallagher LLP
Antoinette C.
McGovern, 212-728-8404
Email:
amcgovern@willkie.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
